VITROS Performance Verifier II
Published April 3, 2024 · Recall initiated: February 27, 2024
Summary
FDA records medical device Class II recall Z-1373-2024, published April 3, 2024 and initiated February 27, 2024. Recalling firm: Ortho-Clinical Diagnostics; Status: Ongoing; Reported quantity: 11,224 units; Lot: Product Code: 8231474; GTIN: 10758750004577; Lot No. R1176. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The issue was mismatched diluent lots assembled into VITRO Chemistry Products Performance Verifier I and II. This issue has the potential to cause erroneous Quality Control (QC) results that could lead to testing delays and erroneous patient results. This issue caused positive or negative bias in the quantification of sodium (Na+) and total carbon dioxide (ECO2). The incorrect diluent into the Performance Verifier II exhibited a potential negative bias of up to 6 mmol/L for ECO2 and Na+ testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ortho-Clinical Diagnostics
- Distributor
- Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Norway, Portugal, Russia, Singapore, Spain, Sweden, The Netherlands, United Kingdom.
- Lot
- Product Code: 8231474; GTIN: 10758750004577; Lot No. R1176.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITROS Performance Verifier IApril 3, 2024
- FDAObsidio Conformable Embolic, Material Numbers (UPN): a) M0013972001010, b) M0013972101010April 3, 2024
- FDAAptima CMV Quant Assay, Reference numbers: AW-22600-001, AW-25509-001, and AW-26381-001 Amplification Reagent,April 3, 2024
- FDAVITROS XT Chemistry Products TBIL-ALKP Slides (ALKP is not affected) In Vitro Diagnostic use only - The TBILSeptember 2, 2020
- FDAVITROS Chemistry Product Performance Verifier I, Product Code 8231474, UDI # 10758750004577 - Product Usage:June 24, 2020
- FDAVITROS chemistry Products K+ Slides, Catalog No. 8157596. MicroSlides which contain reagents in a dry,November 13, 2019
Questions about this recall
Was VITROS Performance Verifier II recalled?
Yes. FDA published recall Z-1373-2024 on April 3, 2024. Reported hazard: The issue was mismatched diluent lots assembled into VITRO Chemistry Products Performance Verifier I and II. This issue has the potential to cause erroneous Quality Control (QC) results that could lead to testing delays and erroneous patient results. This issue caused positive or negative bias in the quantification of sodium (Na+) and total carbon dioxide (ECO2). The incorrect diluent into the Performance Verifier II exhibited a potential negative bias of up to 6 mmol/L for ECO2 and Na+ testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter